Patent Assignment
Reel/Frame 073724/0550
Termination and Release of Intellectual Property Security Agreement (Patents) at Reel 061314 and Frame 0659
Recorded: 2025-08-29
Pages: 7
Assignor
SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
Executed: 2025-08-29
Assignee
TARGANTA THERAPEUTICS CORPORATION
222 THIRD STREET, SUITE 2300, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(5)
Dna Sequences from Staphylococcus Aureus Bacteriophage 77 That Encode Anti-Microbial Polypeptides
Patent:
6,982,153 →
Application:
09/407,804 →
Compositions and Methods Involving an Essential Staphylococcus Aureus Gene and Its Encoded Protein
Patent:
7,101,969 →
Application:
09/689,952 →
Fragments and Variants of Staphylococcus Aureus Dnag Primase, and Uses Thereof
Phosphonated Rifamycins and Uses Thereof for the Prevention and Treatment of Bone and Joint Infections
Methods of Treatment Using Single Doses of Oritavancin
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Assignment of Assignor's Interest
Feb 21, 2019
From: LEHOUX, DARIO; PARR, THOMAS R.; MOECK, GREGORY; ETIENNE, PIERRE
To: TARGANTA THERAPEUTICS CORP.
Reel/Frame 048400/0572 →
Assignment of Assignor's Interest
Feb 21, 2019
From: TARGANTA THERAPEUTICS CORP.
To: THE MEDICINES COMPANY
Reel/Frame 048400/0612 →
Assignment of Assignor's Interest
Feb 21, 2019
From: THE MEDICINES COMPANY
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 048407/0911 →
Amended and Restated Intellectual Property Security Agreement
Aug 25, 2022
From: TARGANTA THERAPEUTICS CORPORATION
To: SILICON VALLEY BANK
Reel/Frame 061314/0659 →
Change of Name
Sep 23, 2025
From: MELINTA THERAPEUTICS, INC
To: MELINTA THERAPEUTICS, LLC
Reel/Frame 072952/0173 →